Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer

Advances in Enzyme Regulation

Volumn 50, Issue 1, 2010, Pages 160-167

  Stein, Gary S ^a   Stein, Janet L ^a   Van Wijnen, Andre J ^a   Lian, Jane B ^a   Montecino, Martin ^b   Croce, Carlo M ^c   Choi, Je Yong ^d   Ali, Syed A ^a   Pande, Sandhya ^a   Hassan, Mohammad Q ^a   Zaidi, Sayyed K ^a   Young, Daniel W ^e  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d Kyungpook National University School of Medicine   (South Korea)

^e Wolf   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHENOTYPE; PROMOTER REGION; REVIEW;

ANIMALS; CELL PROLIFERATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; PHENOTYPE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 77955289442     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2009.10.026     Document Type: Article

References (53)

1. Ali S.A., Zaidi S.K., Dacwag C.S., Salma N., Young D.W., Shakoori A.R., et al. Phenotypic transcription factors epigenetically mediate cell growth control. Proc Natl Acad Sci USA 2008, 105:6632-6637.
2. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001, 107:823-826.
3. Bakshi R., Zaidi S.K., Pande S., Hassan M.Q., Young D.W., Montecino M., et al. The leukemogenic t(8;21) fusion protein AML1-ETO controls ribosomal RNA genes and associates with nucleaolar organizing regions at mitotic chromosomes. J Cell Sci 2008, 21:3981-3990.
4. Barseguian K., Lutterbach B., Hiebert S.W., Nickerson J., Lian J.B., Stein J.L., et al. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Proc Natl Acad Sci USA 2002, 99:15434-15439.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Ben-Ami O., Pencovich N., Lotem J., Levanon D., Groner Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc Natl Acad Sci USA 2009, 106:238-243.
7. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
8. Blyth K., Cameron E.R., Neil J.C. The runx genes: gain or loss of function in cancer. Nat Rev Cancer 2005, 5:376-387.
9. Cruzat F., Henriquez B., Villagra A., Hepp M., Lian J.B., van Wijnen A.J., et al. SWI/SNF-independent nuclease hypersensitivity and increased histone acetylation at the P1 promoter accompany active transcription of the bone master gene Runx2. Biochemistry 2009, 48:7287-7295.
10. Delcuve G.P., Rastegar M., Davie J.R. Epigenetic control. J Cell Physiol 2009, 219:243-250.
11. Durst K.L., Hiebert S.W. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 2004, 23:4220-4224.
12. Erickson P., Gao J., Chang K.S., Look T., Whisenant E., Raimondi S., et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992, 80:1825-1831.
13. Fazzari M.J., Greally J.M. Epigenomics: beyond CpG islands. Nat Rev Genet 2004, 5:446-455.
14. Galindo M., Pratap J., Young D.W., Hovhannisyan H., Im H.J., Choi J.Y., et al. The bone-specific expression of RUNX2 oscillates during the cell cycle to support a G1 related anti-proliferative function in osteoblasts. J Biol Chem 2005, 280:20274-20285.
15. Garzon R., Croce C.M. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008, 15:352-358.
16. Gold M., Hurwitz J., Anders M. The enzymatic methylation of RNA and DNA. Biochem Biophys Res Commun 1963, 11:107-114.
17. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638.
18. Gutierrez J., Paredes R., Cruzat F., Hill D.A., van Wijnen A.J., Lian J.B., et al. Chromatin remodeling by SWI/SNF results in nucleosome mobilization to preferential positions in the rat osteocalcin gene promoter. J Biol Chem 2007, 282:9445-9457.
19. Gutierrez S., Liu J., Javed A., Montecino M., Stein G.S., Lian J.B., et al. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain. J Biol Chem 2004, 279:43581-43588.
20. He S., Davie J.R. Sp1 and Sp3 foci distribution throughout mitosis. J Cell Sci 2006, 119:1063-1070.
21. Ito K., Liu Q., Salto-Tellez M., Yano T., Tada K., Ida H., et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 2005, 65:7743-7750.
22. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
23. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
24. Kim J., Guermah M., McGinty R.K., Lee J.S., Tang Z., Milne T.A., et al. RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 2009, 137:459-471.
25. Lee K.K., Workman J.L. Histone acetyltransferase complexes: one size doesn't fit all. Nat Rev Mol Cell Biol 2007, 8:284-295.
26. Liu C.L., Kaplan T., Kim M., Buratowski S., Schreiber S.L., Friedman N., et al. Single-nucleosome mapping of histone modifications in S. cerevisiae. PLoS Biol 2005, 3:e328.
27. Marks P.A., Richon V.M., Miller T., Kelly W.K. Histone deacetylase inhibitors. Adv Cancer Res 2004, 91:137-168.
28. McNeil S., Zeng C., Harrington K.S., Hiebert S., Lian J.B., Stein J.L., et al. The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc Natl Acad Sci USA 1999, 96:14882-14887.
29. Montecino M., Stein J.L., Stein G.S., Lian J.B., van Wijnen A.J., Cruzat F., et al. Nucleosome organization and targeting of SWI/SNF chromatin-remodeling complexes: contributions of the DNA sequence. Biochem Cell Biol 2007, 85:419-425.
30. Murchison E.P., Hannon G.J. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol 2004, 16:223-229.
31. Ng R.K., Gurdon J.B. Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Nat Cell Biol 2008, 10:102-109.
32. Richards E.J., Elgin S.C. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 2002, 108:489-500.
33. Shen J., Hovhannisyan H., Lian J.B., Montecino M.A., Stein G.S., Stein J.L., et al. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol 2003, 17:743-756.
34. Speck N.A., Gilliland D.G. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2002, 2:502-513.
35. Stein G.S., van Wijnen A.J., Stein J.L., Lian J.B., Montecino M., Zaidi S.K., et al. An architectural perspective of cell-cycle control at the G1/S phase cell-cycle transition. J Cell Physiol 2006, 209:706-710.
36. Stein G.S., Zaidi S.K., Stein J.L., Lian J.B., van Wijnen A.J., Montecino M., et al. Transcription-factor-mediated epigenetic control of cell fate and lineage commitment. Biochem Cell Biol 2009, 87:1-6.
37. Stuardo M., Martinez M., Hidalgo K., Montecino M., Javed A., Lian J.B., et al. Altered chromatin modifications in AML1/RUNX1 breakpoint regions involved in (8;21) translocation. J Cell Physiol 2009, 218:343-349.
38. Sun J.M., Chen H.Y., Espino P.S., Davie J.R. Phosphorylated serine 28 of histone H3 is associated with destabilized nucleosomes in transcribed chromatin. Nucleic Acids Res 2007, 35:6640-6647.
39. Tucker K.L., Talbot D., Lee M.A., Leonhardt H., Jaenisch R. Complementation of methylation deficiency in embryonic stem cells by a DNA methyltransferase minigene. Proc Natl Acad Sci USA 1996, 93:12920-12925.
40. Vradii D., Zaidi S.K., Lian J.B., van Wijnen A.J., Stein J.L., Stein G.S. Point mutation in AML1 disrupts subnuclear targeting, prevents myeloid differentiation, and effects a transformation-like phenotype. Proc Natl Acad Sci. USA 2005, 102:7174-7179.
41. Vradii D., Doan D.N., Wagner S., Nickerson J.A., Lian J.B., Stein J.L., et al. Brg1, the ATPase subunit of SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes. J Cell Physiol 2006, 206:112-118.
42. Westendorf J.J., Hiebert S.W. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J Cell Biochem 1999, 32-33:51-58. Suppl.
43. Westendorf J.J., Zaidi S.K., Cascino J.E., Kahler R., van Wijnen A.J., Lian J.B., et al. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol Cell Biol 2002, 22:7982-7992.
44. Yang G., Thompson M.A., Brandt S.J., Hiebert S.W. Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Oncogene 2007, 26:91-101.
45. Yoo C.B., Jones P.A. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006, 5:37-50.
46. Young D.W., Hassan M.Q., Pratap J., Galindo M., Zaidi S.K., Lee S.H., Yang X., Xie R., Javed A., Underwood J.M., Furcinitti P., Imbalzano A.N., Penman S., Nickerson J.A., Montecino M.A., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 2007, 445:442-446.
47. Young D.W., Hassan M.Q., Yang X.-Q., Galindo M., Javed A., Zaidi S.K., Furcinitti P., Lapointe D., Montecino M., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Mitotic retention of gene expression patterns by the cell fate determining transcription factor Runx2. Proc Natl Acad Sci USA 2007, 104:3189-3194.
48. Zaidi S.K., Young D.W., Pockwinse S.H., Javed A., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Mitotic partitioning and selective reorganization of tissue specific transcription factors in progeny cells. Proc Natl Acad Sci USA 2003, 100:14852-14857.
49. Zaidi S.K., Young D.W., Choi J.Y., Pratap J., Javed A., Montecino M., Stein J.L., van Wijnen A.J., Lian J.B., Stein G.S. The dynamic organization of gene-regulatory machinery in nuclear microenvironments. EMBO Rep 2005, 6:128-133.
50. Zaidi S.K., Javed A., Pratap J., Schroeder T.M., Westendorf J., Lian J.B., van Wijnen A.J., Stein G.S., Stein J.L. Alterations in intranuclear localization of Runx2 affect biological activity. J Cell Physiol 2006, 209:935-942.
51. Zaidi S.K., Young D.W., Javed A., Pratap J., Montecino M., van W.A., Lian J.B., Stein J.L., Stein G.S. Nuclear microenvironments in biological control and cancer. Nat Rev Cancer 2007, 7:454-463.
52. Zaidi S.K., Dowdy C.R., van Wijnen A.J., Lian J.B., Raza A., Stein J.L., et al. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAP kinase network. Cancer Res 2009, 69:8249-8255.
53. Zeng C., van Wijnen A.J., Stein J.L., Meyers S., Sun W., Shopland L., et al. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBFa transcription factors. Proc Natl Acad Sci USA 1997, 94:6746-6751.